Affordable Access

deepdyve-link
Publisher Website

[CYP17A1 inhibitors in prostate cancer: mechanisms of action independent of the androgenic pathway].

Authors
  • Audenet, F
  • Murez, T
  • Ripert, T
  • Villers, A
  • Neuzillet, Y
Type
Published Article
Journal
Progrès en Urologie
Publisher
Elsevier
Publication Date
Oct 01, 2013
Volume
23 Suppl 1
Identifiers
DOI: 10.1016/S1166-7087(13)70041-1
PMID: 24314739
Source
Medline
Keywords
License
Unknown

Abstract

The validation of these mechanisms could contribute to improved therapeutic strategies based on the use of abiraterone acetate alone or in combination.

Report this publication

Statistics

Seen <100 times